Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Weight decreased
Clinical narrative: weight loss 3-5 lbs; Decreased appetite; Patient started feeling very fatigue; low grade fever 100.2; Feels chills often on about 15 days after receiving 2nd dose; Swelling in arm that's injected; shortness of breath on mild excercise; belly discomfort; This spontaneous case was reported by a patient family member or friend and describes the occurrence of PERIPHERAL SWELLING (Swelling in arm that's injected), DECREASED APPETITE (Decreased appetite), DYSPNOEA EXERTIONAL (shortness of breath on mild excercise), WEIGHT DECREASED (weight loss 3-5 lbs) and ABDOMINAL DISCOMFORT (belly discomfort) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 0322200A and 8077727399) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included High cholesterol (Improvement on Atorvastatin) in 2015, Osteopenia (On Actonel x3 mos after 2 years of Rx) in 2012, Hypertension (On Chlorthalidone x 6 mos) in 2020, COVID-19 and Flu. Concomitant products included ATORVASTATIN for High cholesterol, CHLORTHALIDONE and ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) for Hypertension, CALCIUM and RISEDRONATE SODIUM (ACTONEL) for Osteopenia, ATORVASTATIN CALCIUM (LIPITOR), POTASSIUM CITRATE and ESTRADIOL (ESTRING) for an unknown indication.   On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 13-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to .5 milliliter. On 13-Feb-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PERIPHERAL SWELLING (Swelling in arm that's injected). On 02-Mar-2021, the patient experienced DECREASED APPETITE (Decreased appetite), FATIGUE (Patient started feeling very fatigue), PYREXIA (low grade fever 100.2) and CHILLS (Feels chills often on about 15 days after receiving 2nd dose). On an unknown date, the patient experienced DYSPNOEA EXERTIONAL (shortness of breath on mild excercise), WEIGHT DECREASED (weight loss 3-5 lbs) and ABDOMINAL DISCOMFORT (belly discomfort). On 03-Mar-2021, PYREXIA (low grade fever 100.2) and CHILLS (Feels chills often on about 15 days after receiving 2nd dose) had resolved. On 12-Mar-2021, DECREASED APPETITE (Decreased appetite) had resolved. On 03-Apr-2021, FATIGUE (Patient started feeling very fatigue) had resolved. At the time of the report, PERIPHERAL SWELLING (Swelling in arm that's injected) and WEIGHT DECREASED (weight loss 3-5 lbs) outcome was unknown and DYSPNOEA EXERTIONAL (shortness of breath on mild excercise) and ABDOMINAL DISCOMFORT (belly discomfort) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 03-Mar-2021, Influenza virus test: negative Negative. On 03-Mar-2021, SARS-CoV-2 test: negative Negative. On 15-Mar-2021, Chest X-ray: abnormal (abnormal) Inflammation (Non acute interstitial changes).         No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 03-May-2021: Reporter information included. Patient information added. Patient's past history reported. Patient's lab details provided. Suspect product Batch/Lot no. reported. Concomitant medication information added. New events reported. Event outcome reported as recovered/resolved.